| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gritstone bio, Inc. | Director | Common Stock | 128 | $244 | $1.90 | 25 Aug 2021 | Direct |
| Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 12 May 2021 | Direct | ||
| Passage BIO, Inc. | Director, 10%+ Owner | Director Stock Option (Right to Buy) | 24,000 | 25 May 2023 | Direct | ||
| Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 23 Jun 2022 | Direct | ||
| Tempest Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 3,500 | 17 Jun 2022 | Direct | ||
| Gritstone bio, Inc. | Director | Common Stock | 0 | $1.90 | 25 Aug 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PASG | Passage BIO, Inc. | 25 May 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 26 May 2023, 16:38 |
| ALGS | Aligos Therapeutics, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 16:14 |
| TPST | Tempest Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 16:13 |
| PASG | Passage BIO, Inc. | 26 May 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 31 May 2022, 16:33 |
| TPST | Tempest Therapeutics, Inc. | 29 Apr 2022 | 1 | +$5,000,000 | 4 | Director, 10%+ Owner | 03 May 2022, 17:49 |
| GRTS | Gritstone bio, Inc. | 25 Aug 2021 | 6 | $0 | 4 | Director | 27 Aug 2021, 17:49 |
| TPST | Tempest Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4/A | Director | 20 Sep 2021, 20:13 |
| TPST | Millendo Therapeutics, Inc. | 25 Jun 2021 | 3 | $0 | 4 | Director, 10%+ Owner | 29 Jun 2021, 21:54 |
| TPST | Millendo Therapeutics, Inc. | 25 Jun 2021 | 0 | $0 | 3 | Director | 29 Jun 2021, 21:23 |
| ALGS | Aligos Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 17:14 |
| ALGS | Aligos Therapeutics, Inc. | 11 Jun 2021 | 6 | $0 | 4 | Director | 15 Jun 2021, 16:43 |
| PASG | Passage BIO, Inc. | 27 May 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 28 May 2021, 18:06 |
| ADVM | Adverum Biotechnologies, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 20:05 |